Early Check: A Collaborative Innovation to Facilitate Pre-Symptomatic Clinical Trials in Newborns
早期检查:促进新生儿症状前临床试验的协作创新
基本信息
- 批准号:9975249
- 负责人:
- 金额:$ 155.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdvocateAffectAftercareAuthorization documentationAwardBirthChildChild SupportClinical ServicesClinical TrialsCollectionConsentCounselingDataDecision MakingDiseaseEarly InterventionEnsureEvaluationFamilyFoundationsFragile X SyndromeFundingFutureGeneral PopulationGoalsHealthHealth CommunicationHealth Services ResearchIndustryInfantInformaticsInfrastructureIntellectual functioning disabilityInternationalLaboratoriesLearningLifeModelingMotor Neuron DiseaseNeonatal ScreeningNewborn InfantNorth CarolinaOutcomePoliciesPolicy MakerPopulationPositioning AttributeProcessPublic HealthPublic Health InformaticsRare DiseasesRegistriesResearchResearch PersonnelScienceSecureSourceSpinal Muscular AtrophySymptomsTestingTimeTranslational ResearchUniversitiesWorkbasecaregivingdesigneffective therapyexperienceexperimental studyfamily supportfield studyflexibilityfollow-upforestimprovedinnovationmedical schoolspatient advocacy groupprogramspsychosocialpublic-private partnershiprare conditionrecruitscreeningscreening panelscreening policyscreening programsuccesssymptom treatmenttranslational medicine
项目摘要
PROJECT SUMMARY/ABSTRACT
Newborn screening (NBS) is designed for pre-symptomatic identification of serious conditions for which there
are effective treatments that must begin early. Central to NBS policy is evidence that pre-symptomatic
treatment is more effective than treatment after symptoms appear. Unfortunately, such evidence is difficult to
amass because most nominated conditions are rare and the effort required to identify pre-symptomatic
infants for clinical trials is substantial. Researchers and advocates find themselves in a classic “Catch 22”
situation—NBS cannot happen without sufficient evidence, but gathering this evidence necessarily requires
large-scale population screening. This problem is such a formidable barrier to translational research that
many disorders will never have the evidence needed to justify inclusion in NBS programs.
We propose to develop and implement Early Check—a research program in which voluntary screening for a
panel of conditions is offered on a statewide basis. Early Check would allow rapid screening for new
candidate conditions, advance understanding of early disease, and facilitate registry and clinical trial
recruitment. We will build and implement an experimental research program with an ongoing evaluation
component in which we revise and improve the program as we learn from our implementation experiences
and engagement with the general public and families directly affected by screening.
Once we have finalized all aspects of the program, we will offer screening for a gradually expanding set of
conditions to all 120,000 birthing families per year in North Carolina. Our first condition offered for screening
will be spinal muscular atrophy, a life-threatening degenerative motor neuron disorder. We will determine
participation rates; conduct screening; return results; provide counseling and clinical services; support
families in caregiving decisions; inform families of ongoing clinical trials; provide support for families in
deciding whether they want to participate in a clinical trial; and follow children and families over time to study
benefits, harms, and psychosocial outcomes of screening. We will seek external funds to expand Early
Check to other candidate disorders, such as fragile X syndrome. Implementation data will be used to refine
the process, inform replication, and establish an infrastructure for testing other candidate conditions. To
achieve long-term viability, we will develop a model of public-private partnerships based on collaborative
engagement with federal agencies, foundations, patient advocacy groups, and industry.
项目概要/摘要
新生儿筛查 (NBS) 旨在对严重疾病进行症状前识别。
必须尽早开始的有效治疗是国家统计局政策的核心,是在出现症状前提供证据。
不幸的是,这样的证据很难得到。
聚集,因为大多数指定的情况都很罕见,并且需要努力识别症状前
研究人员和倡导者发现自己陷入了经典的“第 22 条军规”。
情况——如果没有足够的证据,NBS 就不可能发生,但收集这些证据必然需要
这个问题是转化研究的巨大障碍。
许多疾病永远不会有必要的证据来证明纳入 NBS 计划的合理性。
我们建议制定并实施早期检查——一项研究计划,其中自愿筛查
一系列条件是在联邦基础上提供的,可以快速筛选新的。
候选条件,促进对早期疾病的了解,并促进注册和临床试验
我们将建立并实施一项实验研究计划,并进行持续评估。
我们从实施经验中学习并修改和改进计划
以及与直接受筛查影响的公众和家庭的接触。
一旦我们完成了该计划的所有方面,我们将提供筛选,逐步扩大范围
我们每年为北卡罗来纳州所有 120,000 个分娩家庭提供筛查条件。
我们将确定将是脊髓性肌萎缩症,一种危及生命的退行性运动神经元疾病。
参与率;返回结果;提供咨询和临床服务;
家庭做出护理决定;告知家庭正在进行的临床试验;为家庭提供支持;
决定他们是否想要参加临床试验;并随着时间的推移跟踪儿童和家庭的研究;
我们将寻求外部资金来扩大早期筛查的益处、危害和心理社会结果。
检查其他候选疾病,例如脆性 X 综合征,将使用实施数据进行细化。
过程,通知复制,并建立测试其他候选条件的基础设施。
为了实现长期生存能力,我们将开发一种基于协作的公私伙伴关系模式
与联邦机构、基金会、患者权益团体和行业的合作。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Education and Consent for Population-Based DNA Screening: A Mixed-Methods Evaluation of the Early Check Newborn Screening Pilot Study.
基于人群的 DNA 筛查的教育和同意:早期检查新生儿筛查试点研究的混合方法评估。
- DOI:
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Peay, Holly L;Gwaltney, Angela You;Moultrie, Rebecca;Cope, Heidi;Boyea, Beth Lincoln;Porter, Katherine Ackerman;Duparc, Martin;Alexander, Amir A;Biesecker, Barbara B;Isiaq, Aminah;Check, Jennifer;Gehtland, Lisa;Bailey Jr, Donald B;King, Nanc
- 通讯作者:King, Nanc
The Future of Newborn Screening: Why and How Partnerships Will Be Needed for Success.
新生儿筛查的未来:为什么以及如何需要合作才能取得成功。
- DOI:
- 发表时间:2019-01
- 期刊:
- 影响因子:0
- 作者:Bailey Jr, Donald B;Zimmerman, Scott J
- 通讯作者:Zimmerman, Scott J
Validation of Fragile X Screening in the Newborn Population Using a Fit-for-Purpose FMR1 PCR Assay System.
使用专用 FMR1 PCR 检测系统验证新生儿脆性 X 筛查。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Lee, Stacey;Taylor, Jennifer L;Redmond, Charles;Hadd, Andrew G;Kemppainen, Jon A;Haynes, Brian C;Shone, Scott;Bailey Jr, Donald B;Latham, Gary J
- 通讯作者:Latham, Gary J
Early Identification of Fragile X Syndrome through Expanded Newborn Screening.
通过扩大新生儿筛查早期识别脆性 X 综合征。
- DOI:
- 发表时间:2019-01-03
- 期刊:
- 影响因子:3.3
- 作者:Okoniewski, Katherine C;Wheeler, Anne C;Lee, Stacey;Boyea, Beth;Raspa, Melissa;Taylor, Jennifer L;Bailey Jr, Donald B
- 通讯作者:Bailey Jr, Donald B
Early Check: A North Carolina Research Partnership.
早期检查:北卡罗来纳州研究合作伙伴。
- DOI:
- 发表时间:2019-01
- 期刊:
- 影响因子:0
- 作者:Gehtland, Lisa M;Bailey, Donald B
- 通讯作者:Bailey, Donald B
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald B Bailey其他文献
Donald B Bailey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald B Bailey', 18)}}的其他基金
Child and Family Consequences of Congenital Zika Syndrome in Brazil
巴西先天性寨卡综合症对儿童和家庭的影响
- 批准号:
9912805 - 财政年份:2017
- 资助金额:
$ 155.7万 - 项目类别:
NORTH CAROLINA: PILOT TEST AND DEVELOPMENT OF NEWBORN SCREENING PROGRAM CAPACITY
北卡罗来纳州:新生儿筛查计划能力的试点测试和发展
- 批准号:
9134040 - 财政年份:2015
- 资助金额:
$ 155.7万 - 项目类别:
Decisional Capacity and Informed Consent in Fragile X Syndrome
脆性 X 综合征的决策能力和知情同意
- 批准号:
8437309 - 财政年份:2012
- 资助金额:
$ 155.7万 - 项目类别:
Decisional Capacity and Informed Consent in Fragile X Syndrome
脆性 X 综合征的决策能力和知情同意
- 批准号:
8554306 - 财政年份:2012
- 资助金额:
$ 155.7万 - 项目类别:
Decisional Capacity and Informed Consent in Fragile X Syndrome
脆性 X 综合征的决策能力和知情同意
- 批准号:
8699808 - 财政年份:2012
- 资助金额:
$ 155.7万 - 项目类别:
FAMILY ADAPTATION TO NEWBORN SCREENING FOR FRAGILE X SYNDROME
家庭对新生儿脆性 X 综合征筛查的适应
- 批准号:
7482836 - 财政年份:2008
- 资助金额:
$ 155.7万 - 项目类别:
ELSI Scale-Up: Large Sample Gene Discovery & Disclosure
ELSI 放大:大样本基因发现
- 批准号:
6831405 - 财政年份:2004
- 资助金额:
$ 155.7万 - 项目类别:
ELSI Scale-Up: Large Sample Gene Discovery & Disclosure
ELSI 放大:大样本基因发现
- 批准号:
6944520 - 财政年份:2004
- 资助金额:
$ 155.7万 - 项目类别:
ELSI Scale-Up: Large Sample Gene Discovery & Disclosure
ELSI 放大:大样本基因发现
- 批准号:
7273900 - 财政年份:2004
- 资助金额:
$ 155.7万 - 项目类别:
相似国自然基金
社会网络关系对公司现金持有决策影响——基于共御风险的作用机制研究
- 批准号:72302067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高尿酸调控TXNIP驱动糖代谢重编程影响巨噬细胞功能
- 批准号:82370895
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
倒装芯片超声键合微界面结构演变机理与影响规律
- 批准号:52305599
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
寒地城市学区建成环境对学龄儿童心理健康的影响机制与规划干预路径研究
- 批准号:52378051
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
原位研究聚变燃料纯化用Pd-Ag合金中Ag对辐照缺陷演化行为的影响及其相互作用机制
- 批准号:12305308
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Cognitive and neural mechanisms of cognitive-behavioral therapy for avoidant/restrictive food intake disorder
回避/限制性食物摄入障碍的认知行为疗法的认知和神经机制
- 批准号:
10570372 - 财政年份:2023
- 资助金额:
$ 155.7万 - 项目类别:
Interaction of Schistosomiasis mansoni and hepatitis B virus infections on hepatocellular carcinoma
曼氏血吸虫病和乙型肝炎病毒感染对肝细胞癌的相互作用
- 批准号:
10471416 - 财政年份:2020
- 资助金额:
$ 155.7万 - 项目类别:
Interaction of Schistosomiasis mansoni and hepatitis B virus infections on hepatocellular carcinoma
曼氏血吸虫病和乙型肝炎病毒感染对肝细胞癌的相互作用
- 批准号:
10259887 - 财政年份:2020
- 资助金额:
$ 155.7万 - 项目类别:
Interaction of Schistosomiasis mansoni and hepatitis B virus infections on hepatocellular carcinoma
曼氏血吸虫病和乙型肝炎病毒感染对肝细胞癌的相互作用
- 批准号:
10084616 - 财政年份:2020
- 资助金额:
$ 155.7万 - 项目类别:
Interaction of Schistosomiasis mansoni and hepatitis B virus infections on hepatocellular carcinoma
曼氏血吸虫病和乙型肝炎病毒感染对肝细胞癌的相互作用
- 批准号:
10689175 - 财政年份:2020
- 资助金额:
$ 155.7万 - 项目类别: